News

Sable Resources Ltd.: Sable Completes VTEM Geophysical Survey at the Copper Queen Project in British Columbia

Sable Resources Ltd. ("Sable" or the "Company") (TSXV:SAE | OTCQB:SBLRF) is pleased to announce that the Company has ...

Lennox International Inc.: Lennox Signs Agreement to Acquire HVAC Division of NSI Industries

Strategic acquisition expands parts and supplies portfolio for commercial and residential HVAC customers. DALLAS, Aug. 18, ...

Genius Group Limited: Genius Group Provides Update on Legal Cases

Genius Group Limited (NYSE American: GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education ...

Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AGBahnhof Park 46340, Baar, SwitzerlandMedia Relations ContactMadhu [email protected] ...

Pelthos Therapeutics, Inc.: Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

Files Quarterly Report on Form 10-Q detailing financial results for legacy operations for the three and six months ended June 30, 2025Strong physician response following successful launch of ZELSUVMI ...

Diginex Limited Announces Completion of Definitive Agreement to Acquire Matter DK ApS, Expanding Its Sustainability Data and AI Capabilities

Diginex Limited ("Diginex") (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced the signing of a definitive agreement for ...

NexPoint Real Estate Finance, Inc.: NexPoint Real Estate Finance (NREF) Announces Dual Listing on NYSE Texas

NexPoint Real Estate Finance, Inc. (NYSE: NREF) (the "Company") announced today the dual listing of its common stock on NYSE ...

Anixa Biosciences, Inc.: Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial

Fourth Cohort Receiving 30x Initial Dose with No Dose-Limiting Toxicities Observed to Date SAN JOSE, Calif., Aug. 18, 2025 /PRNewswire/ -- Anixa Biosciences, Inc.

SUNation Energy, Inc.: SUNation Energy Announces 2025 Second Quarter Results and Reiterates Full Year Financial Guidance

FY 2025 Total Sales Expected to Rise 14% - 23% from FY 2024 with Positive Adjusted EBITDA Q2 2025 Select Highlights Gross Margin Expanded to 37%Total Debt Declined by $11.7 Million, a 61% Improvement ...

Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine

First-in-human trial of Capricor's StealthX vaccine initiated under HHS's Project NextGenTrial conducted and funded by the National Institute of Allergy and Infectious Diseases (NIAID) SAN DIEGO, ...

SaverOne 2014 Ltd.: SaverOne Broadens its Relationship with Cemex: An Additional European Cemex Division Deploys SaverOne's Driver Distraction Prevention System

Marks Continued Growth in SaverOne's Global Footprint and Further Expansion Within Cemex's Operations Petah Tikvah, Israel, Aug. 18, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SV ...

Opus Genetics, Inc.: Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1

Phase 1/2 trial expected to initiate in 2H 2025 in patients with BEST1 inherited retinal disease RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD), a clinical ...